Beta blockers, used for decades after heart attacks, provide no benefit for patients with preserved heart function, according to the REBOOT trial. The massive study also found women faced higher risks when taking the drug. Experts say the results will change heart treatment guidelines worldwide.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- Gene-edited CAR-T cells erase aggressive T-cell leukemia
- Blood tests reveal obesity rapidly accelerates Alzheimer’s progression
- Scientists say this viral rosemary skincare trend actually works
- Gas stoves are filling millions of homes with hidden toxic air
- A routine shingles shot may offer powerful defense against dementia
- Your skin has a built-in cancer defense and sunlight turns it off
- RSV prevention in newborns could cut asthma risk
- Scientists discover hidden wolf DNA in most dogs
- Millions are about to choose the wrong Medicare plan
- Bird flu’s surprising heat tolerance has scientists worried
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
